Avanos Medical (AVNS) Set to Announce Quarterly Earnings on Thursday

Avanos Medical (NYSE:AVNS) will be announcing its earnings results on Thursday, May 2nd. Analysts expect the company to announce earnings of $0.21 per share for the quarter. Avanos Medical has set its FY24 guidance at $1.30-1.45 EPS.Investors that are interested in participating in the company’s conference call can do so using this link.

Avanos Medical (NYSE:AVNS) last announced its quarterly earnings data on Tuesday, February 20th. The company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.01). The firm had revenue of $173.30 million for the quarter, compared to the consensus estimate of $170.43 million. Avanos Medical had a negative net margin of 8.76% and a positive return on equity of 4.25%. Avanos Medical’s revenue for the quarter was down 4.6% on a year-over-year basis. During the same period last year, the company posted $0.60 earnings per share. On average, analysts expect Avanos Medical to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Avanos Medical Stock Performance

Shares of NYSE AVNS traded up $0.26 during mid-day trading on Friday, hitting $18.11. The company had a trading volume of 7,421 shares, compared to its average volume of 276,243. The stock’s 50-day moving average price is $19.26 and its 200-day moving average price is $19.92. The company has a market capitalization of $836.68 million, a price-to-earnings ratio of -13.72 and a beta of 0.96. The company has a current ratio of 2.08, a quick ratio of 1.38 and a debt-to-equity ratio of 0.13. Avanos Medical has a 1 year low of $17.24 and a 1 year high of $30.28.

Insider Buying and Selling at Avanos Medical

In other Avanos Medical news, CFO Michael Greiner sold 8,000 shares of Avanos Medical stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $19.12, for a total value of $152,960.00. Following the completion of the sale, the chief financial officer now owns 151,495 shares of the company’s stock, valued at approximately $2,896,584.40. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 2.90% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded Avanos Medical from a “hold” rating to a “buy” rating in a research note on Tuesday, March 19th.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.